Research & publications
Research that shapes supportive cancer care
More than 38 peer-reviewed publications and roughly 2,700 citations — from validated patient tools to international consensus guidelines.
Focus
Where I concentrate my research
My research centres on the adverse events of targeted therapy, immunotherapy and endocrine treatment — with particular depth in dermatologic (skin) and oral, mucosal toxicities, and in the patient-reported outcomes that measure them.
Selected publications
A selection of the work
A full, current publication list is available via Google Scholar and ResearchGate. Citation metrics are approximate and self-reported.
Tools & instruments
Methods clinicians and researchers can use
The TARGET System
A six-step method for assessing, grading and managing adverse events in practice and in research protocols.
FACT-EGFRI-18
A validated quality-of-life instrument for measuring the skin toxicity of EGFR-inhibitor therapy, which she co-developed.